FOFlora Magno de Jesus Oliveira

Flora Magno de Jesus Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flora Magno de Jesus Oliveira has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Na/K-ATPase assay in the intact mice lung subjected to perfusion

    by Cassiano Felippe Gonçalves-De-Albuquerque, Patrícia Burth, Adriana Ribeiro Silva, IsabelMatos Medeiros de Moraes, FloraMagno Jesus de Oliveira, Ricardo Erthal Santelli, Aline Soares Freire, Mauricio Younes-Ibrahim, Hugo Caire de Castro-Faria-Neto, Mauro Velho de Castro-Faria

    Among the characteristics of acute respiratory distress syndrome (ARDS) is edema formation and its resolution depends on pneumocyte Na/K-ATPase activity. Increased concentration of oleic acid (OA) in plasma induces lung injury by targeting Na/K-ATPase and, thus, interfering in sodium transport. Presently, we adapted a radioactivity-free assay to detect Na/K-ATPase activity in perfused lung mice, comparing the inhibitory effect of ouabain and OA. We managed to perfuse only the lung, avoiding the systemic loss of rubidium. Rb+ incorporation into lung was measured by inductively coupled plasma optical emission spectrometry (ICP OES) technique, after lung tissue digestion. Na/K-ATPase activity was the difference between Rb+ incorporation with or without ouabain. Lung Na/K-ATPase was completely inhibited by perfusion with ouabain. However, OA caused a partial inhibition. In the present work the amount of incorporated Rb+ was greater than seen in our previous report, showing that the present technique is trustworthy. This new proposed assay may allow researchers to study the importance of Na/K-ATPase activity in lung pathophysiology.


  • Open Access

    Murine lung injury caused by Leptospira interrogans glycolipoprotein, a specific Na/K-ATPase inhibitor

    by Cassiano Felippe Gonçalves-De-Albuquerque, Patrícia Burth, Adriana Ribeiro Silva, Isabel Matos Medeiros de Moraes, Flora Magno de Jesus Oliveira, Ricardo Erthal Santelli, Aline Soares Freire, Gerson Silva de Lima, Emilson Domingos da Silva, Camila Ignácio da Silva, et al.

    Leptospiral glycolipoprotein (GLP) is a potent and specific Na/K-ATPase inhibitor. Severe pulmonary form of leptospirosis is characterized by edema, inflammation and intra-alveolar hemorrhage having a dismal prognosis. Resolution of edema and inflammation determines the outcome of lung injury. Na/K-ATPase activity is responsible for edema clearance. This enzyme works as a cell receptor that triggers activation of mitogen-activated protein kinase (MAPK) intracellular signaling pathway. Therefore, injection of GLP into lungs induces injury by triggering inflammation. We injected GLP and ouabain, into mice lungs and compared their effects. Bronchoalveolar lavage fluid (BALF) was collected for cell and lipid body counting and measurement of protein and lipid mediators (PGE2 and LTB4). The levels of the IL-6, TNFα, IL-1B and MIP-1α were also quantified. Lung images illustrate the injury and whole-body plethysmography was performed to assay lung function. We used Toll-like receptor 4 (TLR4) knockout mice to evaluate leptospiral GLP-induced lung injury. Na/K-ATPase activity was determined in lung cells by nonradioactive rubidium incorporation. We analyzed MAPK p38 activation in lung and in epithelial and endothelial cells. Leptospiral GLP and ouabain induced lung edema, cell migration and activation, production of lipid mediators and cytokines and hemorrhage. They induced lung function alterations and inhibited rubidium incorporation. Using TLR4 knockout mice, we showed that the GLP action was not dependent on TLR4 activation. GLP activated of p38 and enhanced cytokine production in cell cultures which was reversed by a selective p38 inhibitor. GLP and ouabain induced lung injury, as evidenced by increased lung inflammation and hemorrhage. To our knowledge, this is the first report showing GLP induces lung injury. GLP and ouabain are Na/K-ATPase targets, triggering intracellular signaling pathways. We showed p38 activation by GLP-induced lung injury, which was may be linked to Na/K-ATPase inhibition. Lung inflammation induced by GLP was not dependent on TLR4 activation.


  • Open Access

    Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production

    by Cassiano F Gonçalves-De-Albuquerque, Patrícia Burth, Adriana R Silva, Isabel Matos M de Moraes, Flora M de Jesus Oliveira, Ricardo Santelli, Aline S Freire, Patrícia T Bozza, Mauricio Younes-Ibrahim, Hugo C de Castro-Faria-Neto, et al.

    Acute respiratory distress syndrome (ARDS) can emerge from certain pathologies, such as sepsis, fat embolism and leptospirosis, in which the levels of unesterified fatty acids are increased in the patient’s plasma. ARDS is characterized by edema formation, and edema resolution occurs mainly due to the pneumocyte Na/K-ATPase activity. As previously described, increased oleic acid (OA) plasma concentrations induce lung injury by interfering with sodium transport. The first aim of this study was to develop a radioactivity-free assay to detect Na,K-ATPase activity ex vivo using a model of OA-induced lung injury in mice. We also investigated the relationship between Na/K-ATPase inhibition and OA-induced lung injury using ouabain-induced lung injury as a comparison, because of the well-described effect of ouabain as a Na/K-ATPase inhibitor.


  • Open Access

    HMG-CoA reductase inhibitor simvastatin improves organ dysfunction, inflammatory profile, bacterial clearance and cognitive damage after onset of sepsis

    by Magno Flora, Medeiros-De-Moraes Isabel, Bozza Fernando, Silva Adriana, Castro-Faria-Neto Hugo

    Sepsis is a clinical syndrome characterized by systemic inflammatory response secondary to infection, which can progress to multiple organ dysfunction and death. Cognitive impairment is a significant consequence of sepsis reported among survivors. Despite research on new therapies, sepsis treatment remains based on life support and antibiotics. Cohort studies have suggested that statin uses are associated with protection from development and mortality of sepsis. Statins have pleiotropic effects and they are emerging as potent inhibitors of inflammatory processes. In this study we aimed to evaluate the effects of simvastatin in a clinical relevant model of sepsis in rodents (Cecal Ligation and Puncture-CLP). Swiss Webster mice were submitted to CLP and 6h later they were treated with simvastatin (2mg/kg – iv). Plasma and peritoneal lavage were collected for organ damage evaluation, cytokine (ELISA) and nitric oxide (NO) (Griess method) quantification, cell migration and bacterial clearance (colony forming units-CFU) analysis. Cognitive damage was evaluated through inhibitory avoidance task. Our results showed that simvastatin decreased liver and kidney damage, and significantly reduced neutrophils numbers, CFU counts, TNF, MIF, IL-6 and IL1 levels in the peritoneum. Simvastatin decreased NO levels in the bloodstream, but it enhanced NO production in the peritoneum. Additionally, simvastatin prevented the loss of aversive memory in septic mice. Our study demonstrates that simvastatin improved inflammatory profile and bacterial elimination in sepsis, preventing organ dysfunction and late consequences of sepsis. Our study indicates that statins can be considered potential candidate to future clinical studies as adjuvant therapy for sepsis.